top
Search terms
Results 1 - 3 of 3 - ordered by :
Escardio

According to current clinical practice guidelines, prasugrel and ticagrelor have equal, Class I recommendations for use following percutaneous coronary intervention (PCI) in acute coronary syndromes ...

Date : 02/09/2019
Escardio

Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular ...

Date : 03/09/2019
Escardio

ESC guidelines recommend a short period of triple therapy (oral anticoagulant, aspirin, clopidogrel) followed by a period of dual therapy (oral anticoagulant plus aspirin or clopidogrel) in atrial ...

Date : 03/09/2019